An inherited tendency to make these antibodies was linked to higher diabetes risk in data from 300,000 people. The antibodies target IL-6 (Interleukin-6), a protein that helps immune cells send messages. Antibodies usually help defend the body. But some target its own proteins instead. This study looked at inherited differences linked to making antibodies against seven immune signals. Researchers first studied 15,000 people in the Danish Blood Donor Study. They found 52 areas of DNA linked to these antibodies. They then used those findings to build scores estimating each person's inherited tendency to make them. Those scores were compared with disease records from 300,000 people in the Copenhagen Hospital Biobank. A higher inherited tendency to make antibodies against this immune signal was linked to higher diabetes risk. The source does not give the size of that increase. It also does not show that the antibodies caused diabetes. The wider finding was that antibodies against different immune signals had different links to disease risk. This is not the same as measuring the immune signal itself. For BioSocial members tracking blood levels, that distinction matters. This study does not establish a blood-level target or show that lowering a reading prevents diabetes. When comparing your numbers with the community, the exact test name matters. A blood-level result, an antibody test, and an inherited-risk score answer different questions. Keeping those separate can make shared lab results easier to understand. What have you learned from tracking your inflammation-related blood results alongside your blood sugar numbers?